Headlines

ACM Research And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – ACM Research (ACMR), Insulet (PODD), Dycom Industries (DY) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. ACM Research (ACMR)

62% sales growth and 10.62% return on equity

ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.

Earnings Per Share

As for profitability, ACM Research has a trailing twelve months EPS of $1.08.

PE Ratio

ACM Research has a trailing twelve months price to earnings ratio of 15.04. Meaning, the purchaser of the share is investing $15.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.62%.

Yearly Top and Bottom Value

ACM Research’s stock is valued at $16.24 at 10:22 EST, way below its 52-week high of $22.47 and way above its 52-week low of $8.75.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ACM Research’s EBITDA is 26.09.

2. Insulet (PODD)

23.6% sales growth and 23.18% return on equity

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Earnings Per Share

As for profitability, Insulet has a trailing twelve months EPS of $1.71.

PE Ratio

Insulet has a trailing twelve months price to earnings ratio of 111.77. Meaning, the purchaser of the share is investing $111.77 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.18%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 27%, now sitting on 1.56B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 34.7% and 87%, respectively.

Sales Growth

Insulet’s sales growth is 24.7% for the ongoing quarter and 23.6% for the next.

Moving Average

Insulet’s value is below its 50-day moving average of $201.54 and way below its 200-day moving average of $217.99.

3. Dycom Industries (DY)

15.2% sales growth and 23.04% return on equity

Dycom Industries, Inc. provides specialty contracting services in the United States. The company offers various specialty contracting services, including program management, engineering, construction, maintenance, and installation services, such as placement and splicing of fiber, copper, and coaxial cables to telecommunications providers. It also provides tower construction, lines and antenna installation, foundation and equipment pad construction, and small cell site placement for wireless carriers, as well as equipment installation and material fabrication, and site testing services; and installs and maintains customer premise equipment, such as digital video recorders, set top boxes, and modems for cable system operators. In addition, the company offers construction and maintenance services for electric and gas utilities, and other customers; and underground facility locating services, such as locating telephone, cable television, power, water, sewer, and gas lines for various utility companies, including telecommunication providers. Dycom Industries, Inc. was incorporated in 1969 and is headquartered in Palm Beach Gardens, Florida.

Earnings Per Share

As for profitability, Dycom Industries has a trailing twelve months EPS of $7.41.

PE Ratio

Dycom Industries has a trailing twelve months price to earnings ratio of 15.69. Meaning, the purchaser of the share is investing $15.69 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.04%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Dycom Industries’s EBITDA is 19.57.

Sales Growth

Dycom Industries’s sales growth is 5.4% for the current quarter and 15.2% for the next.

4. Interactive Brokers Group (IBKR)

11.1% sales growth and 21.9% return on equity

Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.

Earnings Per Share

As for profitability, Interactive Brokers Group has a trailing twelve months EPS of $2.84.

PE Ratio

Interactive Brokers Group has a trailing twelve months price to earnings ratio of 37.03. Meaning, the purchaser of the share is investing $37.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.9%.

Moving Average

Interactive Brokers Group’s value is way higher than its 50-day moving average of $88.65 and way above its 200-day moving average of $85.02.

Yearly Top and Bottom Value

Interactive Brokers Group’s stock is valued at $105.07 at 10:22 EST, under its 52-week high of $106.43 and way higher than its 52-week low of $70.83.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Interactive Brokers Group’s EBITDA is 8.93.

5. Sprouts Farmers Market (SFM)

6.6% sales growth and 23.56% return on equity

Sprouts Farmers Market, Inc. offers fresh, natural, and organic food products in the United States. The company offers perishable product categories, including fresh produce, meat, seafood, deli, bakery, floral and dairy, and dairy alternatives; and non-perishable product categories, such as grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care. As of January 2, 2022, it operated 374 stores in 23 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

Earnings Per Share

As for profitability, Sprouts Farmers Market has a trailing twelve months EPS of $2.43.

PE Ratio

Sprouts Farmers Market has a trailing twelve months price to earnings ratio of 21.23. Meaning, the purchaser of the share is investing $21.23 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.56%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 7.1% and a drop 1% for the next.

Volume

Today’s last reported volume for Sprouts Farmers Market is 803499 which is 35.49% below its average volume of 1245690.

6. GlaxoSmithKline (GSK)

6.3% sales growth and 46.38% return on equity

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Earnings Per Share

As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $3.01.

PE Ratio

GlaxoSmithKline has a trailing twelve months price to earnings ratio of 13.95. Meaning, the purchaser of the share is investing $13.95 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.38%.

Volume

Today’s last reported volume for GlaxoSmithKline is 2836700 which is 16.93% below its average volume of 3414920.

Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $41.99 at 10:22 EST, below its 52-week high of $42.23 and way higher than its 52-week low of $33.20.

Leave a Reply

Your email address will not be published. Required fields are marked *